Skip to main content
Clinical Trials/NCT01893463
NCT01893463
Withdrawn
Not Applicable

Prospective Study to Evaluate the Safety and Effectiveness of the iTClamp50 to Provide Temporary Wound Closure

Innovative Trauma Care Inc.1 site in 1 countryAugust 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemorrhage
Sponsor
Innovative Trauma Care Inc.
Locations
1
Primary Endpoint
Number of Adverse Events
Status
Withdrawn
Last Updated
12 years ago

Overview

Brief Summary

Early and effective control of severe bleeding is critical to survival of trauma patients. The iTClamp™50 is a Health Canada approved medical device for temporary wound/skin closure that quickly controls bleeding by sealing the skin. Similar to a clip, the device seals the skin edges within a pressure bar, enabling the creation of a hematoma where blood collects under pressure to form a stable clot until definitive repair. The iTClamp50 is indicated for use as a skin closure device for short-term soft tissue approximation, including use in trauma wounds, lacerations, junctional bleeds or surgical incisions. The purpose of this prospective clinical study is to evaluate the effectiveness and safety of the iTClamp50 in the ambulance (pre-hospital) and emergency department setting. This will be accomplished by observing patients with the device applied from the pre-hospital through to patient discharge. The hypothesis is that the iTClamp50 will be safe and effective at providing temporary wound closure to control hemorrhage in the pre-hospital and emergency department setting.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
December 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Innovative Trauma Care Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The device is indicated for use to control external hemorrhage from all compressible areas and to close wounds on the torso (chest and abdomen). The final decision to apply the device will be left with the care provider; however, their rationale will be reviewed in the post-use questionnaire.

Exclusion Criteria

  • The device is contraindicated for application to specific regions (e.g., eyes and genitals), application on patients less than the size of maturity, and wounds in which the skin edges cannot be approximated.

Outcomes

Primary Outcomes

Number of Adverse Events

Time Frame: Until patient discharge

Effectiveness of the iTClamp50 to control hemorrhage

Time Frame: Patient discharge (Varies)

As measured by length of time to control bleeding and evidence of re-bleeding

Secondary Outcomes

  • Pain associated with application and removal of the iTClamp50(Patient discharge (varies))

Study Sites (1)

Loading locations...

Similar Trials